Beranda › Kanker Paru Non-Sel Kecil › New York › Albany
Uji klinis Kanker Paru Non-Sel Kecil di Albany, NY
9 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Albany (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Menerima pesertaFase 3
- New York Oncology Hematology, P.C. ( Site 0132), Albany
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Menerima pesertaFase 3
- New York Oncology Hematology, P.C. ( Site 0119), Albany
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Menerima pesertaFase 3
- New York Oncology Hematology, P.C. ( Site 9000), Albany
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Menerima pesertaFase 3
- New York Oncology Hematology P.C ( Site 9000), Albany
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- New York Oncology Hematology, Albany
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Menerima pesertaFase 2/3
- New York Oncology Hematology - Albany Medical Center, Albany
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Menerima pesertaFase 2
- ONE Onc: New York Oncology Hematology, Albany
MYLUNG Consortium Part 3: Observational Study
Menerima pesertaStudi observasional
- New York Oncology Hematology, P.C., Albany
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- New York Oncology Hematology, Albany
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Albany
- Penyakit Kardiovaskular7 studi
- Gagal Jantung6 studi
- Obesitas6 studi
- Kanker (semua jenis)5 studi
- Stroke4 studi
- Tekanan Darah Tinggi4 studi
- Limfoma Burkitt4 studi
- Mieloma Multipel4 studi
- Penyakit Alzheimer4 studi
- Penyakit Pencernaan4 studi
- Kanker Kandung Kemih4 studi
- Kanker Payudara4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.